Patients face an increasingly complex decision when deciding where to go for their cancer treatment. There are several factors that can aid in that decision-making process including location, center designation, physician experience, physician referral, health plan coverage, and options for treatment. In addition to these factors, nationally accepted quality measures, outcome data, and patient satisfaction information can also be helpful tools in comparisons between cancer treatment centers or hospitals.
Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center acknowledge the seven American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) evidence-based quality guidelines for breast and colorectal cancers. View the latest performance data for the Breast Cancer Program and Gastrointestinal Cancers Program in the treatment of these diseases.
The National Marrow Donor Program tracks data on patients who have received a transplant at accredited United States Transplant Centers. Yale Cancer Center's actual results are above the predicted survival range. The following chart shows how Yale Cancer Center compares to Transplant Centers in the United States reporting more than 50 allogeneic transplants during the most recent reporting period (2010 – 2012). For a complete listing of the performance data visit the Yale Cancer Center website.
